Kaori F. Fujimoto-Ouchi
Product Research Department
Chugai Pharmaceuticals Co.
Ltd, 200 Kajiwara
Kamakura
Japan
Name/email consistency: high
- Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy. Fujimoto-Ouchi, K., Sekiguchi, F., Yamamoto, K., Shirane, M., Yamashita, Y., Mori, K. Cancer Chemother. Pharmacol. (2010)
- Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models. Fujimoto-Ouchi, K., Onuma, E., Shirane, M., Mori, K., Tanaka, Y. Cancer Chemother. Pharmacol. (2007)
- Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models. Fujimoto-Ouchi, K., Sekiguchi, F., Yasuno, H., Moriya, Y., Mori, K., Tanaka, Y. Cancer Chemother. Pharmacol. (2007)
- Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models. Ouchi, K.F., Yanagisawa, M., Sekiguchi, F., Tanaka, Y. Cancer Chemother. Pharmacol. (2006)